✦ LIBER ✦

Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial

✍ Scribed by Skorupski, K. A.; Uhl, J. M.; Szivek, A.; Allstadt Frazier, S. D.; Rebhun, R. B.; Rodriguez, C. O.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity and efficacy of a novel doxorub

✍ AE Lane; ML Black; KM Wyatt 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Alternating Carboplatin and Doxorubicin

✍ Michael S. Kent; Adam Strom; Cheryl A. London; Bernard Seguin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Phase I trial of paclitaxel, doxorubicin

✍ M. SHIMADA; J. KIGAWA; N. TERAKAWA; A. YOSHIZAKI; T. SHOJI; M. SUZUKI; M. HATAE; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Carboplatin and pegylated liposomal doxo

✍ Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 124 KB

Randomized phase III trial of three vers

✍ Jeffrey Bell; Mark F. Brady; Robert C. Young; Janice Lage; Joan L. Walker; Kathe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 522 KB

Re: “Randomized phase III trial of three

✍ Maurie Markman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 388 KB